Immune responses to an encapsulated allogeneic islet β-cell line in diabetic NOD mice
- 3 February 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 340 (1), 236-243
- https://doi.org/10.1016/j.bbrc.2005.11.180
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A human β-cell line for transplantation therapy to control type 1 diabetesNature Biotechnology, 2005
- Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitroBiomaterials, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- Xenotransplantation: Infectious Risk RevisitedAmerican Journal of Transplantation, 2004
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- MHC Class II–Dependent Abnormal Reactivity Toward Bacterial Superantigens in Immune Cells of NOD MiceDiabetes, 1997
- Flow cytometric identification of murine neutrophils and monocytesJournal of Immunological Methods, 1996
- Clonal Insulinoma Cell Line That Stably Maintains Correct Glucose ResponsivenessDiabetes, 1994
- Complement Lytic Activity Has No Role in the Pathogenesis of Autoimmune Diabetes in NOD MiceDiabetes, 1993
- Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal isletsDiabetologia, 1993